DEF: Wellgistics Health Proposes Name Change and Stock Plan Amendments

Wellgistics Health, Inc. is holding a special meeting on May 21, 2026, to vote on a name change to Vantix Health Inc., authorizing preferred stock, and amending its equity incentive plan.

Summary

• Wellgistics Health, Inc. is convening a Special Meeting of Stockholders on May 21, 2026, to vote on three key proposals.
• The first proposal is to change the company's name from Wellgistics Health, Inc. to Vantix Health Inc. to better align with its business model as a healthcare technology and pharmaceutical services platform.
• The second proposal seeks to authorize 10,000,000 shares of blank check preferred stock, providing the company with financial and strategic flexibility for future transactions.
• The third proposal aims to amend the 2023 Equity Incentive Plan by increasing the number of shares available for issuance by 56,493,936, bringing the total to 100,000,000 shares, and adjusting the annual increase to 10% of outstanding shares.
• The meeting will be conducted virtually, and stockholders of record as of April 22, 2026, are eligible to vote.
• The Board of Directors unanimously recommends voting FOR all three proposals.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it outlines strategic changes and a plan for future growth, but also highlights potential dilution risks for existing shareholders.

Positives

• The proposed name change to Vantix Health Inc. is intended to better reflect the company's strategic focus on healthcare technology and pharmaceutical services.
• Authorization of preferred stock provides the company with enhanced financial and strategic flexibility for future growth opportunities.
• The significant increase in the equity incentive plan's share reserve aims to support anticipated growth, attract and retain talent, and align employee interests with stockholders.
• The virtual meeting format allows for broader stockholder participation regardless of location.

Negatives

• The authorization of preferred stock and the increase in the equity incentive plan's share reserve could lead to dilution of existing stockholders' equity ownership, voting power, and earnings per share.
• The potential for future share issuances, particularly of preferred stock, could have anti-takeover effects, potentially deterring or delaying a change in control.
• The ownership of certain shares by Brian Norton is currently the subject of ongoing litigation with the Company.

Risks

• The potential dilution of existing stockholders' equity and voting power due to the authorization of preferred stock and the increased equity incentive plan share reserve.
• The possibility that the newly authorized preferred stock could be issued in a manner that is not favorable to common stockholders, potentially affecting dividends or liquidation preferences.
• The ongoing litigation between the Company and Brian Norton regarding the beneficial ownership of certain shares.

Future Outlook

The company is seeking to change its name to Vantix Health Inc. and authorize preferred stock to enhance financial and strategic flexibility. The equity incentive plan amendment is intended to support anticipated growth and equity compensation needs over multiple years.

Management Comments

• "I am pleased to invite you to attend the Special Meeting of Stockholders of Wellgistics Health, Inc., a Delaware corporation, which will be held on May 21, 2026, at 1pm Eastern Time."
• "The Special Meeting will be conducted in a virtual format to provide stockholders the opportunity to attend, irrespective of location."
• "Whether or not you attend the Special Meeting online, it is important that your shares be represented and voted at the Special Meeting. Therefore, I urge you to promptly vote and submit your proxy via the Internet, by phone, or by mail."
• "The Board believes that the proposed name change will better align the Company's corporate identity with its current business model and strategic focus as a healthcare technology and pharmaceutical services platform, and will provide a clearer and more cohesive brand as the Company continues to execute on its integrated micro health ecosystem strategy."
• "The Board believes that equity-based compensation is a critical component of the Company's overall compensation program and is essential to attracting, retaining and motivating key employees, officers, directors and consultants."

Industry Context

StockSavvy.ai notes that the proposed name change to Vantix Health Inc. and the focus on a 'micro health ecosystem' with integrated solutions in pharmaceuticals and healthcare services aligns with broader industry trends towards consolidation, specialization, and technology-driven patient care models. The expansion of equity incentive plans is a common strategy for growth-stage companies in the healthcare and technology sectors to attract and retain talent.

Corporate Governance

Legal Proceedings

• The ownership of certain shares by Brian Norton is currently the subject of ongoing litigation between the Company and Mr. Norton.

Stakeholder Impact

• Shareholders: Potential dilution of ownership and voting power from preferred stock and equity incentive plan increases; potential for future strategic transactions and growth. Stockholders are urged to vote on the proposals.
• Employees: Increased opportunity for equity-based compensation through the expanded incentive plan, aiding in attraction and retention.
• Management: The name change and strategic alignment may support future business development. Management is recommending approval of all proposals.

Next Steps

• Stockholders to vote on the three proposals at the Special Meeting on May 21, 2026.
• If approved, the Certificate of Amendment for the name change will be filed with the Secretary of State of the State of Delaware.
• If approved, the Certificate of Amendment for the preferred stock authorization will be filed with the Secretary of State of the State of Delaware.
• If approved, the Incentive Plan will be amended to reflect the increased share reserve and revised annual increase.
• Final voting results will be disclosed in a Form 8-K filing with the SEC within four business days after the Special Meeting.

Key Dates

Recommendation

The filing outlines significant corporate changes including a name change and expansion of authorized stock and equity incentives. While these could support future growth, the potential for substantial dilution and ongoing litigation introduces uncertainty. A 'hold' recommendation allows investors to await further developments and clarity on the strategic execution and impact of these changes.

Keywords

Proxy Statement, Special Meeting, Name Change, Vantix Health Inc., Preferred Stock, Equity Incentive Plan, Stockholder Vote, Wellgistics Health, Inc., Corporate Governance, Share Dilution